article thumbnail

Magazine: Advancing islet transplantation for type 1 diabetes

Pharmaceutical Technology

In this issue: Diabetes researchers oppose the regulation of islet transplantation as a biologic in the US, why haemophilia gene therapies are so expensive, how AI will help with trial recruitment.

article thumbnail

Magazine: ‘Right shoring’ API production in Europe

Pharmaceutical Technology

Also in this month’s issue, we take a look at the innovative type 1 diabetes therapy by Provention Bio called Tzield. More than a century after an individual with type 1 diabetes was treated with insulin for the first time, the FDA approved Tzield, the first and only treatment to delay the onset of type 1 diabetes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Researchers Present Key Research Results on Diabetes Remission of Dorzagliatin

Pharma Mirror

The post Researchers Present Key Research Results on Diabetes Remission of Dorzagliatin appeared first on Pharma Mirror Magazine. The DREAM study is an observational, non-pharmacologic and non-interventional clinical study initiated by certain researchers participating in the.

article thumbnail

SAEM Clinical Images Series: My Mom Could Not See

ALiEM - Pharm Pearls

An 87-year-old female with a history of hypertension, hyperlipidemia, chronic kidney disease stage IIIB, type 2 diabetes mellitus, and schizophrenia presented for evaluation due to sudden visual loss in her right eye, which began 12 hours before she arrived at the emergency department. American Academy of Ophtalmology Eyenet magazine.

Diabetes 130
article thumbnail

Navigating the NHS as a digital start-up

pharmaphorum

“COVID has forced the NHS to change, but so far most of the implemented digital innovations have been low-hanging fruit such as video consultations,” says Rory Cameron, CEO and co-founder at diabetes risk management app Gendius. Adoption of new tech is still a real challenge.”.

article thumbnail

Modernizing Therapeutic Cell Production

Pharma Mirror

With the promise of significant breakthroughs in treatment of diabetes, cancer, and congenital conditions, it is no wonder that research and development is predicted to reach $232.5 billion by 2026, up from $186 billion in 2019 according to the Evaluate Pharma report.

article thumbnail

What Changes To Your Lifestyle Need To Be Done After Bariatric Surgery

Pharma Mirror

It reduces and even eliminates diabetes in many people and seriously reduces the risk of heart disease. The post What Changes To Your Lifestyle Need To Be Done After Bariatric Surgery appeared first on Pharma Mirror Magazine. Getting bariatric surgery is a lifesaver for many people. The weight loss can be dramatic as well.